CVR 28291736Public limited company (A/S)Fremstilling af olier og fedtstoffer (104100)KalundborgFounded 25 Nov 2004
CVR registers no owner holding 5% or more.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about PRONOVA BIOPHARMA DANMARK A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
100
CVR registry, 2013
Revenue
419.1M
DKK, annual report 2013
Result
-58.1M
DKK, annual report 2013
Equity
933.7M
DKK, annual report 2013
CVR registers no owner holding 5% or more.
Carsten Hjorth Jensenuntil 28 Jan 2014
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
25 Nov 2004 to 4 Nov 2026.
2013, annual: 100 employees, 102 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 89 | 105 | No count | No count | No count | No count | 91 | 98 | 100 |
| FTE | 1 | 52 | 102 | 105 | 108 | 105 | 103 | 97 | 97 | 102 |
| Series | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 2007 to 2009 and 2011 to 2013; quarterly Q1 2010 to Q4 2010.
Latest 2013, published 14 May 2016. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|---|
| Revenue | Not reported | Not reported | Not reported | Not reported | 419,117 |
| Operating profit | Not reported | Not reported | Not reported | Not reported | -85,183 |
| Result for the year | Not reported | Not reported | Not reported | Not reported | -58,117 |
| Equity | Not reported | Not reported | Not reported | Not reported | 933,700 |
| Total assets | Not reported | Not reported | Not reported | Not reported | 1,240,264 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 102 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | Not reported | Not reported | Not reported | Not reported | -13.2% |
| EBIT margin (overskudsgrad) | Not reported | Not reported | Not reported | Not reported | -20.3% |
| EBITDA | Not reported | Not reported | Not reported | Not reported | 283,454 |
| EBITDA margin | Not reported | Not reported | Not reported | Not reported | 67.6% |
| Employee growth (vækst i antal ansatte) | Not reported | Not reported | Not reported | Not reported | 5.1% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | Not reported | Not reported | Not reported | Not reported | 42,137 |
| Gearing, NIBD / EBITDA | Not reported | Not reported | Not reported | Not reported | 0.1x |
| ROIC (afkast af investeret kapital) | Not reported | Not reported | Not reported | Not reported | -6.7%note 1 |
| Capex (investeringer i anlægsaktiver) | Not reported | Not reported | Not reported | Not reported | 33,692 |
| Capex % of sales (investeringer i procent af omsætningen) | Not reported | Not reported | Not reported | Not reported | 8% |
| FCFF / EBITDA (pengestrømskonvertering) | Not reported | Not reported | Not reported | Not reported | -6%note 1 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | Not reported | Not reported | Not reported | Not reported | 167,105 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions.
Annual report 2013
1 Jan 2013 to 31 Dec 2013, published 31 Jan 2014
Annual report 2012
1 Jan 2012 to 31 Dec 2012, published 18 Apr 2013
Annual report 2011
1 Jan 2011 to 31 Dec 2011, published 17 Apr 2012
Annual report 2010
1 Jan 2010 to 31 Dec 2010, published 10 Apr 2011
Annual report 2009
1 Jan 2009 to 31 Dec 2009, published 4 May 2010
Each registered value from the day it took effect, newest first.
Merger (Fusion), as the ceasing company (Ophørende selskab)
From CVR, read 4 Nov 2026. Text such as the signing rule and purpose is shown as registered.
16 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Selskabet opløst efter fusion med CVR-NR. 17412612 BASF A/S.
Erhvervsstyrelsen har modtaget fusionsplan
for den påtænkte fusion mellem
CVR-NR. 17412612 BASF A/S (fortsættende), der tillige driver virksomhed under navnene A/S BADILIN, BASF DANMARK A/S, DANOCHEMO A/S, BASF VITAMINFABRIK A/S, BASF HEALTH & NUTRTION A/S, BASF CONSTRUCTION CHEMICALS DENMARK A/S, NBK A/S, NORDISK BYGGE KEMI A/S, BASF CC DANMARK A/S, A/S ALFRED GAD, BTC SPECIALITY CHEMICAL DISTRIBUTION A/S, BASIS KEMI A/S, BTC NORDIC A/S, WINTERSHALL DANMARK ØSTERSØEN A/S.
CVR-NR. 28291736 PRONOVA BIOPHARMA DANMARK A/S (ophørende).
Der er endvidere modtaget erklæring fra
vurderingsmændene om, at kreditorerne i
Bestyrelse:
Udtrådt af bestyrelsen:
Morten Jurs, den 26.06.2013, Synne Hermansen Røine, den 26.06.2013.
Indtrådt i bestyrelsen:
Ralf Fink (formand), den 26.06.2013, Charlotte Berg-Svendsen, den 26.06.2013.
Bestyrelse:
Udtrådt af bestyrelsen:
Kjetil Olsen, den 15.12.2010.
Indtrådt i bestyrelsen:
Trygve Christophersen, den 15.12.2010.
Direktion:
Udtrådt af direktionen:
Kjetil Olsen, den 15.12.2010.
Indtrådt i direktionen:
Direktør Carsten Hjorth Jensen, den 15.12.2010.
Vedtægter ændret:
21.12.2009.
Kapitalforhøjelse:
kr. 10.000,00 indbetalt ved konvertering af gæld, kurs 4.455.000,00.
Kapitalen udgør herefter kr. 520.000,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Per-Oluf Olsen, den 01.07.2009.
Indtrådt i bestyrelsen:
Synne Hermansen Røine, den 03.07.2009.
Bestyrelse:
Udtrådt af bestyrelsen:
Tomas Settevik, den 21.11.2008.
Indtrådt i bestyrelsen:
Per-Oluf Olsen, den 21.11.2008.
Vedtægter ændret:
11.06.2008.
Kapitalforhøjelse:
kr. 10.000,00 indbetalt ved konvertering af gæld, kurs 3.744.400,00.
Kapitalen udgør herefter kr. 510.000,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Trygve Christophersen, den 04.04.2008.
Indtrådt i bestyrelsen:
Direktør Kjetil Olsen, den 04.04.2008.
Direktion:
Udtrådt af direktionen:
Tomas Settevik, den 01.04.2008.
Indtrådt i direktionen:
Direktør Kjetil Olsen, den 04.04.2008.
Vedtægter ændret:
28.12.2007.
Ny adresse:
Juelsmindevej 5, postboks 64, 4400 Kalundborg.
Ny kommune:
Kalundborg.
Vedtægter ændret:
27.08.2007.
Nyt navn:
PRONOVA BIOPHARMA DANMARK A/S.
Vedtægter ændret:
20.03.2007.
Nyt navn:
PRONOVA BIOCARE DENMARK A/S.
Ny adresse:
c/o Bech-Bruun Advokatfirma, Langelinie Allé 35, 2100 København Ø.
Bestyrelse:
Udtrådt af bestyrelsen:
Stine Monefeldt Holm, den 20.03.2007, Britta Madsen, den 20.03.2007, Steen Schierbeck, den 20.03.2007.
Indtrådt i bestyrelsen:
Morten Jurs (formand), den 20.03.2007, Trygve Christophersen, den 20.03.2007, Tomas Settevik, den 20.03.2007.
Direktion:
Udtrådt af direktionen:
Steen Schierbeck, den 20.03.2007.
Indtrådt i direktionen:
Tomas Settevik, den 20.03.2007.
Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør og af to bestyrelsesmedlemmer i forening.
Revision:
Udtrådt af revisionen:
Henrik Ulvsgaard, den 20.03.2007.
Indtrådt i revisionen:
CVR-NR. 24213714 DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB, Weidekampsgade 6, 2300 København S, den 20.03.2007.
Bestyrelse:
Udtrådt af bestyrelsen:
Svend Carstensen, den 01.03.2006.
Indtrådt i bestyrelsen:
Advokatfuldmægtig Stine Monefeldt Holm, den 01.03.2006.
Stiftelsesdato:
25.11.2004.
Seneste vedtægtsdato:
25.11.2004.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
kontant kr. 500.000,00 til kurs 100,00.
Stifter:
CVR-NR. 10139597 ASX 9667 ApS, Store Kongensgade 118, 1264 København K, den 25.11.2004.
Bestyrelse:
Advokat Svend Carstensen, den 25.11.2004, Advokatsekretær Britta Madsen, den 25.11.2004, Advokat Steen Schierbeck, den 25.11.2004.
Direktion:
Advokat Steen Schierbeck, den 25.11.2004.
Selskabet tegnes af direktør eller den samlede bestyrelse.
Revision:
Statsaut. revisor Henrik Ulvsgaard, 1364 København K, den 25.11.2004.
Første regnskabsår:
25.11.2004 - 31.12.2005.
Regnskabsår:
01.01 - 31.12.
1 registered in CVR.
P-number 1010984706Juelsmindevej 5, 4400 Kalundborg
